| Product Code: ETC10709389 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 New Zealand Opioid Use Disorder Market Overview |
3.1 New Zealand Country Macro Economic Indicators |
3.2 New Zealand Opioid Use Disorder Market Revenues & Volume, 2021 & 2031F |
3.3 New Zealand Opioid Use Disorder Market - Industry Life Cycle |
3.4 New Zealand Opioid Use Disorder Market - Porter's Five Forces |
3.5 New Zealand Opioid Use Disorder Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.6 New Zealand Opioid Use Disorder Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 New Zealand Opioid Use Disorder Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.8 New Zealand Opioid Use Disorder Market Revenues & Volume Share, By Therapy Type, 2021 & 2031F |
4 New Zealand Opioid Use Disorder Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increased awareness about opioid use disorder and its consequences among healthcare professionals and the general public. |
4.2.2 Rising prevalence of chronic pain conditions leading to higher prescription rates of opioids. |
4.2.3 Government initiatives and policies aimed at improving access to treatment and support for individuals with opioid use disorder. |
4.3 Market Restraints |
4.3.1 Stigma associated with opioid use disorder leading to underreporting and lack of seeking treatment. |
4.3.2 Regulatory challenges and restrictions on opioid prescribing practices. |
4.3.3 Limited availability of specialized healthcare professionals and treatment facilities for opioid use disorder. |
5 New Zealand Opioid Use Disorder Market Trends |
6 New Zealand Opioid Use Disorder Market, By Types |
6.1 New Zealand Opioid Use Disorder Market, By Treatment Type |
6.1.1 Overview and Analysis |
6.1.2 New Zealand Opioid Use Disorder Market Revenues & Volume, By Treatment Type, 2021 - 2031F |
6.1.3 New Zealand Opioid Use Disorder Market Revenues & Volume, By Medication-Assisted Treatment (MAT), 2021 - 2031F |
6.1.4 New Zealand Opioid Use Disorder Market Revenues & Volume, By Behavioral Therapy, 2021 - 2031F |
6.1.5 New Zealand Opioid Use Disorder Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.1.6 New Zealand Opioid Use Disorder Market Revenues & Volume, By Support Programs, 2021 - 2031F |
6.2 New Zealand Opioid Use Disorder Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 New Zealand Opioid Use Disorder Market Revenues & Volume, By Buprenorphine, 2021 - 2031F |
6.2.3 New Zealand Opioid Use Disorder Market Revenues & Volume, By Methadone, 2021 - 2031F |
6.2.4 New Zealand Opioid Use Disorder Market Revenues & Volume, By Naltrexone, 2021 - 2031F |
6.2.5 New Zealand Opioid Use Disorder Market Revenues & Volume, By Naloxone, 2021 - 2031F |
6.3 New Zealand Opioid Use Disorder Market, By Distribution Channel |
6.3.1 Overview and Analysis |
6.3.2 New Zealand Opioid Use Disorder Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 New Zealand Opioid Use Disorder Market Revenues & Volume, By Clinics, 2021 - 2031F |
6.3.4 New Zealand Opioid Use Disorder Market Revenues & Volume, By Specialty Centers, 2021 - 2031F |
6.3.5 New Zealand Opioid Use Disorder Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4 New Zealand Opioid Use Disorder Market, By Therapy Type |
6.4.1 Overview and Analysis |
6.4.2 New Zealand Opioid Use Disorder Market Revenues & Volume, By Long-Term, 2021 - 2031F |
6.4.3 New Zealand Opioid Use Disorder Market Revenues & Volume, By Outpatient, 2021 - 2031F |
6.4.4 New Zealand Opioid Use Disorder Market Revenues & Volume, By Residential, 2021 - 2031F |
6.4.5 New Zealand Opioid Use Disorder Market Revenues & Volume, By Harm Reduction, 2021 - 2031F |
7 New Zealand Opioid Use Disorder Market Import-Export Trade Statistics |
7.1 New Zealand Opioid Use Disorder Market Export to Major Countries |
7.2 New Zealand Opioid Use Disorder Market Imports from Major Countries |
8 New Zealand Opioid Use Disorder Market Key Performance Indicators |
8.1 Number of individuals seeking treatment for opioid use disorder. |
8.2 Rate of successful treatment outcomes and relapse rates. |
8.3 Utilization of non-pharmacological pain management strategies in healthcare settings. |
9 New Zealand Opioid Use Disorder Market - Opportunity Assessment |
9.1 New Zealand Opioid Use Disorder Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
9.2 New Zealand Opioid Use Disorder Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 New Zealand Opioid Use Disorder Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.4 New Zealand Opioid Use Disorder Market Opportunity Assessment, By Therapy Type, 2021 & 2031F |
10 New Zealand Opioid Use Disorder Market - Competitive Landscape |
10.1 New Zealand Opioid Use Disorder Market Revenue Share, By Companies, 2024 |
10.2 New Zealand Opioid Use Disorder Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here